Debate
Session 7 : ER+Ve Breast Cancer
Chairpersons :
P P Bapsy, Shailesh Talati
Fulvestrant is the appropriate 1st line option for low volume metatstatic Er+Ve disease -Chanchal Goswami
VS
Letrozole + Palbociclib is the appropriate 1st line option for low volume metatstatic Er+Ve disease - Chirag Desai